CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 161 enrolled
Drug / intervention
Standard Acupuncture / Moxibustion +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03855111
NCT03855111N/ACompleted

Symptom Management Efficacy Study to Reduce Distal Neuropathic Pain

New York University·interventional·Posted Feb 26, 2019·Updated May 19, 2026

In Brief

A clinical study evaluating Standard Acupuncture / Moxibustion and Individualized (Tailored) Active Acupuncture / Moxibustion for Neuropathic Pain and 3 related conditions. Completed, enrolled 161 participants across 1 site.

Detailed Summary

Distal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with HIV. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely ineffective. In HIV there are no FDA-approved drugs for this indication. This study assesses in a randomized controlled clinical trial, the efficacy of novel non-pharmacologic pain management approaches to reduce HIV-related DSP pain and improve quality of life.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 26, 2019
Enrollment StartJan 14, 2019
Primary CompletionOct 21, 2024
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 7.4 years ago

Interventions

Standard Acupuncture / Moxibustionother

Standard (Fixed) Active Acupuncture / Moxibustion protocol aimed at reducing lower limb neuropathic pain/discomfort.

Individualized (Tailored) Active Acupuncture / Moxibustionother

Individualized (tailored) protocol Acu/Moxa - Active. Acu/Moxa prescription based on TCM assessment. Protocol aimed at reducing lower limb neuropathic pain/discomfort.